ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 130 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2024. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $789,189 | +91.2% | 255,401 | +59.6% | 0.01% | +40.0% |
| Q1 2024 | $412,800 | +175.2% | 160,000 | +166.7% | 0.01% | +150.0% |
| Q4 2023 | $150,000 | +28.9% | 60,000 | +4.7% | 0.00% | +100.0% |
| Q3 2023 | $116,386 | -11.7% | 57,333 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $131,866 | -27.5% | 57,333 | -4.4% | 0.00% | -66.7% |
| Q1 2023 | $181,800 | +30.0% | 60,000 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $139,800 | +35.7% | 60,000 | +11.2% | 0.00% | 0.0% |
| Q3 2022 | $103,000 | -29.5% | 53,940 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $146,000 | -18.4% | 53,940 | -10.1% | 0.00% | 0.0% |
| Q1 2022 | $179,000 | -23.2% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $233,000 | +66.4% | 60,000 | +42.3% | 0.00% | -33.3% |
| Q1 2021 | $140,000 | -61.6% | 42,171 | -59.0% | 0.00% | -50.0% |
| Q4 2020 | $365,000 | +8.0% | 102,765 | -4.8% | 0.01% | -14.3% |
| Q3 2020 | $338,000 | +72.4% | 107,912 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $196,000 | +345.5% | 107,912 | +270.8% | 0.01% | +150.0% |
| Q3 2019 | $44,000 | -27.9% | 29,104 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $61,000 | – | 29,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 16,013,540 | $39,233,000 | 1.19% |
| ARMISTICE CAPITAL, LLC | 1,940,000 | $4,753,000 | 1.12% |
| DAFNA Capital Management LLC | 234,000 | $573,000 | 0.50% |
| Alpha Wave Global, LP | 1,655,162 | $4,055,000 | 0.43% |
| Telemetry Investments, L.L.C. | 150,000 | $368,000 | 0.21% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 5,294,945 | $12,972,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 792,617 | $1,942,000 | 0.11% |
| K2 PRINCIPAL FUND, L.P. | 443,887 | $1,088,000 | 0.10% |
| Anson Funds Management LP | 105,085 | $257,000 | 0.08% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 25,000 | $61,000 | 0.03% |